You are here

neurology

Neurology-focused Brenig Therapeutics raises $65M in series A financing

FinSMEs

Tue, 07/23/24 - 11:27 am

Brenig Therapeutics

5 Neuro Data Readouts to Watch in the Second Half of 2024

BioSpace

Mon, 07/15/24 - 11:43 am

clinical trials

Alzheimer's disease

Cerevel Therapeutics

Neumora Therapeutics

major depressive disorder

Wolfram syndrome

Vigil Neuroscience

Roche partners with RNA editing biotech Ascidian

BioPharma Dive

Tue, 06/18/24 - 11:31 am

Ascidian Therapeutics

RNA exon editing

drug development

BIO: Jazz is auditioning new bandmates in an M&A market ripe with talent

Fierce Biotech

Tue, 06/6/23 - 11:16 am

Jazz Pharmaceuticals

Novartis, Biogen Scrap Gene Regulation Partnerships with Sangamo

BioSpace

Mon, 03/20/23 - 09:51 am

Sangamo Therapeutics

gene regulation therapies

Rare disease and neurology take outs tick higher

EP Vantage

Wed, 03/2/22 - 10:03 am

Bristol Myers Squibb

Gilead Sciences

Jazz Pharmaceuticals

Eliem raises $60M to take neuro programs to series of data drops

Fierce Biotech

Mon, 05/24/21 - 11:04 am

Eliem Therapeutics

neuronal excitability disorders

AI-designed serotonin tracker could help develop neurology drugs

Pharmaforum

Sat, 12/26/20 - 08:19 pm

artificial intelligence

Neurology at Forefront of FDA’s Complex Innovative Trial Design Pilot

Xconomy

Thu, 04/16/20 - 10:48 am

clinical trials

Dr. Reddy’s to sell neurology branded products to Upsher-Smith Laboratories

Pharmaceutical Business Review

Mon, 06/17/19 - 09:52 am

Pfizer, Merck, J&J well-positioned for M&A and Biogen and BioMarin are prime targets: report

Fierce Pharma

Wed, 02/20/19 - 11:59 am

Atlas ramps up a new biotech player focused on neurology, with a $30M round to fund the work

Endpoints

Tue, 09/19/17 - 10:15 pm

Disarm Therapeutics

King cancer: The top 10 therapeutic areas in biopharma R&D

Endpoints

Tue, 07/18/17 - 10:49 pm

cardiovascular disease

Valeant: We're raising prices, but not much

BioPharma Dive

Mon, 10/17/16 - 11:27 am

Valeant Pharmaceutcals

gastrointestinal

AbbVie’s Therapies in Virology, Neurology, and Women’s Health

Yahoo/Market Realist

Wed, 03/16/16 - 09:58 am

Valeant Responds to Price Critics, May Sell Neurology Drugs Unit

Bloomberg

Mon, 10/19/15 - 10:20 am

Valeant Pharmaceuticals

Fidelity, Sanofi back $75M round for Jeremy Levin's neurology startup

Fierce Biotech

Thu, 08/13/15 - 08:41 am

Ovid Therapeutics

Interview: How 4.5MM Late-Stage Neuro Patients Drive Opportunity For MRI Interventions

Tue, 09/18/12 - 10:54 pm

Salt Lake Regional Offers an Implantable Neurostimulation System

Thu, 12/8/11 - 10:39 pm

CareFusion Launches Wireless Diagnostic and Monitoring Neurological Device

Fri, 12/2/11 - 08:55 pm

Pages